Compare OPTT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTT | PYPD |
|---|---|---|
| Founded | 1984 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 86.6M |
| IPO Year | 2006 | 2014 |
| Metric | OPTT | PYPD |
|---|---|---|
| Price | $0.36 | $4.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $1.50 | ★ $12.25 |
| AVG Volume (30 Days) | ★ 2.7M | 42.6K |
| Earning Date | 03-17-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,861,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $221.57 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $0.29 | $2.44 |
| 52 Week High | $0.90 | $5.12 |
| Indicator | OPTT | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 45.89 |
| Support Level | $0.34 | $4.29 |
| Resistance Level | $0.39 | $5.05 |
| Average True Range (ATR) | 0.01 | 0.19 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 35.70 | 25.45 |
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.